INAB - IN8bio Inc
1.72
-0.020 -1.163%
Share volume: 9,288
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.74
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-13-2025 | 05-07-2025 | 11-06-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 8.645 M | 8.689 M | 6.041 M | 6.224 M | 5.660 M | 3.967 M | |
| Selling general and admin | 3.742 M | 3.533 M | 2.732 M | 2.630 M | 2.688 M | 1.863 M | |
| Research and development | 4.903 M | 5.156 M | 3.309 M | 3.594 M | 2.972 M | 2.104 M | |
| Total expenses | 8.645 M | 8.689 M | 6.041 M | 7.292 M | 5.660 M | 3.967 M | |
| 0.51% | -30.48% | 20.71% | -22.38% | -29.91% | |||
| Operating income | -8.562 M | -8.629 M | -7.086 M | -6.160 M | -5.550 M | -3.854 M | |
| Ebit | -8.562 M | -8.629 M | -7.086 M | -6.160 M | -5.550 M | -3.854 M | |
| Pretax income | -8.479 M | -8.569 M | -6.018 M | -7.141 M | -5.550 M | -3.854 M | |
| 1.06% | -29.77% | 18.66% | -22.28% | -30.56% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -8.562 M | -8.629 M | -6.018 M | -7.228 M | -5.550 M | -3.854 M | |
| -0.78% | 30.26% | -20.11% | 23.22% | 30.56% |